Mostafa Bahaa
Clinical trials sponsored by Mostafa Bahaa, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could an asthma drug ease Parkinson's symptoms? Results expected Nov 2026 (estimated)
- Could a common diabetes drug ease knee arthritis pain? Results expected Nov 2026 (estimated)
- Which dental implant size keeps lower dentures more secure? Results expected Aug 2027 (estimated)
-
Could a common diabetes drug tame ulcerative colitis?
Disease control CompletedThis study tests whether dapagliflozin, a drug currently used for diabetes, can help control inflammation in people with mild-to-moderate ulcerative colitis. Researchers will give 50 adults either dapagliflozin plus standard mesalamine or mesalamine alone, and track changes in sy…
Phase 2/3 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Sep 21, 2026 19:00 UTC
-
Can a diabetes drug fight gout? metformin takes on febuxostat
Disease control CompletedResearchers compare two drugs, metformin and febuxostat, for lowering uric acid in obese adults who have gout but not diabetes. Both drugs may reduce uric acid, the substance that forms painful crystals in joints. The trial measures changes in blood uric acid levels over time. Ab…
Phase 2 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Common antibiotic may boost diabetes control
Disease control CompletedResearchers test whether adding doxycycline to sitagliptin helps control blood sugar and heart health in adults over 40 with newly diagnosed type 2 diabetes. Participants receive both drugs, and the team tracks changes in fasting blood sugar and HbA1c. The trial also measures hea…
Phase 1/2 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for type 1 diabetes: can common diabetes drugs improve blood sugar control?
Disease control CompletedThis study tests whether adding empagliflozin or semaglutide to insulin can improve blood sugar control in overweight or obese adults with type 1 diabetes. About 105 participants will take one of the two drugs or a placebo for 3 months. The goal is to see if these drugs help lowe…
Phase 2 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Antidepressant shows promise for arthritis relief in new trial
Disease control CompletedThis phase 3 trial tested whether adding paroxetine, an antidepressant, to standard methotrexate therapy can better control rheumatoid arthritis. 100 adults with active RA took part. The main goal was to see if the combination lowers disease activity scores more than methotrexate…
Phase 3 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could an allergy drug protect kidneys in diabetes?
Disease control CompletedThis study tested whether levocetirizine, an allergy medication, can reduce protein leakage in the urine of people with diabetic kidney disease. The trial enrolled 60 adults aged 40-65 with type 2 diabetes and early kidney damage. Researchers measured changes in albuminuria to se…
Phase 2 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could an old antibiotic tame ulcerative colitis?
Disease control CompletedThis study tested whether adding the antibiotic minocycline to standard mesalamine treatment helps control mild-to-moderate ulcerative colitis. 46 adults took part. Researchers measured disease activity using a symptom score. The trial is complete, but results are not yet publish…
Phase 2 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Keyhole surgery blood loss study compares tying techniques
Knowledge-focused CompletedThis study looked at 60 women aged 35 to 60 who had a hysterectomy (removal of the uterus) through small cuts in the belly (laparoscopy). The goal was to compare two different methods of tying off the uterine arteries to see which one led to less blood loss during surgery. The re…
Sponsor: Mostafa Bahaa • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC